Fri 28 Aug 2026 International edition
Clinical Trials & Research Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer
Oncology & Cancer Research Hijacking the Body’s Defenses: How Triple-Negative Breast Cancer Co-Opts Immune Cells to Build Nerve Networks and Fuel Tumor Growth
Laboratory Medicine From "Spooky Science" to Modern Infrastructure: A Century of Quantum Mechanics
Pathology & Histology Breakthrough in Computational Pathology: Introducing PRISM2, the First Clinical-Grade Multimodal Slide-Level Foundation Model
Hematology & Blood Research Executive Overview
Toxicology & Pharmacology Unlocking the Brain’s Hidden Machinery: Breakthrough Yale Study Reveals How GLP-1 Medications Actually Sustain Weight Loss
Healthcare News & Policy Rethinking the Sweet Tooth: Six-Month Clinical Trial Challenges Global Public Health Dogma on Dietary Sweetness
Clinical Immunology The Thermal Immune Boost: How Finnish Sauna Sessions Mobilize the Body’s Defense Systems
Clinical Trials & Research Ivonescimab Scores Landmark Phase III Win in Biliary Tract Cancer, Solidifying Summit and Akeso’s High-Stakes Bet
Laboratory Medicine Decoding the Titans of the Cosmos: How Ultraheavy Particles are Rewriting Modern Astrophysics
Healthcare Quality & Safety Bridging the Digital Divide: A New Scoping Review Targets Technological Solutions to Low Cervical Cancer Screening Uptake
Biochemistry & Metabolomics Decoding the Avian Blueprint: How Artificial Intelligence and Museum Archives Rewrote 45 Million Years of Songbird Evolution

Archive

Tag: revolutionizing